A stroke registry was established in the Eastern Province of Saudi Arabia with an estimated population of 750,000 inhabitants of whom 545,000 are Saudi citizens. The register started in July 1989 and ended in July 1993. The Gulf war led to its interruption from August 1990 to August 1991. Four hundred eighty-eight cases (314 males, 174 females) of first-ever strokes affecting Saudi nationals were registered over the 3-year period. The crude incidence rate for first-ever strokes was 29.8/100,000/year (95% CI: 25.2–34.3/100,000 year). When standardized to the 1976 US population, it rose up to 125.8/100,000/year. Ischemic strokes (69%) predominated as in other studies but subarachnoid hemorrhage (SAH) was extremely rare (1.4%). The important risk factors were: systemic hypertension (38%), diabetes mellitus (37%), heart disease (27%), smoking (19%) and family history of stroke (14%). Previous transient ischemic attacks (3%) and carotid bruits (1%) were uncommon. The 30-day case fatality rate was 15%. The study showed that the age-adjusted stroke incidence rate for Saudis in this region is lower than the rates reported in developed countries but within the range reported worldwide. The pattern of stroke in Saudi Arabia is not different from that reported in other communities with the exception of the low incidence of SAH. The risk factors are similar to findings in other studies except for the high frequency of diabetes mellitus in our cases. The lower mortality rate was probably due to the younger age of the population and the availability of free medical services for management of cases.

Keywords:
Cerebrovascular disease, Epidemiology, Saudi Arabia
1.
Pisa Z, Uemura K: Trends in mortality from ischemic heart disease and other cardiovascular diseases in 27 countries 1968–1977. World Health Statistics, WHO 1982;35:11–47.
2.
Bonita R: Epidemiology of stroke. Lancet 1992;339:342–344.
3.
Broderick JP, Philips SJ, Whisnant JP, et al: Incidence rates of stroke in the eighties: The end of the decline in stroke? Stroke 1989;20:577–582.
4.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB: Probability of stroke: A risk profile from the Framingham Study. Stroke 1991;22:312–318.
5.
Bronner LL, Kanter DS, Mason JE: Primary prevention of stroke. N Engl J Med 1995;333:1392–1400.
6.
Gorelick PB: Stroke prevention. Arch Neurol 1995;52:347–355.
7.
Howard G, Walker MD, Becker C, Coull B, et al: Community hospital-based stroke programs: North Carolina, Oregon, and New York. III. Factors influencing survival after a stroke: Proportional hazards. Analysis of 4219 patients. Stroke 1986;17:294–299.
8.
Al-Rajeh S, Larbi E, Bademosi O, Awada A, Ismail H, Freihi H: Pattern and ethnic variations in stroke in Saudi Arabia. J Neurol Sci 1991;102:112–118.
9.
Ammar A, Al-Rajeh S, Ibrahim AWM, Choudary UM, Awada A: Pattern of subarachnoid hemorrhage in Saudi Arabia. Acta Neurochir (Wien) 1992;114:16–19.
10.
Al-Rajeh S, Awada A, Niazi G, Larbi E: Stroke in a Saudi Arabian National Guard Community. Analysis of 500 consecutive cases from a population-based hospital. Stroke 1993;24:1635–1639.
11.
Awada A, Al Rajeh S, D’Arbela PG, Larbi E, Bdeir MB: Cardiac disorders in stroke patients. A study from Saudi Arabia. Trop Cardiol 1995;21:69–75.
12.
Ministry of Municipalities of Rural Affairs, Kingdom of Saudi Arabia: Current situation in Dammam area. Project No. 204, 5th Report, 1979, pp 296–307.
13.
Hatano S: Control of stroke in the community – methodological considerations and protocol of WHO stroke register. Working document for meeting on community control and hypertension. Geneva, 6–13 December, 1973 (WHO document WHO CVD/S/73.6 Rev 1).
14.
Baum HM, Robins M: National survey of stroke. Stroke 1981;12(suppl 1):59–68.
15.
Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics, ed 2. Los Altos, Lange, 1994, pp 143–161.
16.
Bamford J, Sandercock P, Dennis M, Warlow C, et al: A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981–86. Methodology, demographic and incident of cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373–1380.
17.
Tanaka H: Age-specific incidence of stroke subtypes in Shibata Japan 1976–1978. Stroke 1982;13:110.
18.
Al-Rajeh S, Bademosi O, Awada A, Ismail H, Dawodu A, Al-Freihi H, Assuhaimi S, Borollosi M, Shammasi S: Community survey of neurological disorders in Saudi Arabia: Results of Thugbah Study in the Eastern province of Saudi Arabia. Neuroepidemiology 1993;12:164–178.
19.
Alter M, Zhang ZX, Sobel E, Fisher M, Davanipour Z, Friday G: Standardized incidence of ratios of stroke: a worldwide review. Neuroepidemiology 1986;5:148–158.
20.
Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T: Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull World Health Organ 1980;58(1):113–130.
21.
Fatani HH, Mira SA, El Zubeir AG: Prevalence of diabetes mellitus in Saudi Arabia. Diabetes Care 1987;10:180–183.
22.
Osuntokun BO, Bademosi O, Akinkugbe OO, Oyediran ABO, Carlisle RC: Incidence of stroke in an African city: Results from stroke registry at Ibadan, Nigeria. Stroke 1979;10:205–207.
23.
Dennis MS, Bamford JM, Sandercock PAG, Warlow CP: Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 1989;20:333–339.
24.
Al Rajeh S, Awada A, Naufal R, Amene P, Larbi E, Obeid T: Angiographic patterns of carotid ischemic cerebrovascular disease in Saudi Arabia. J Neurol Sci 1995;134:167–170.
25.
Al Awamy BH, El Muzan M, Al Turki M, Sergeant GR: Neonatal screening for sickle-cell disease in the Eastern Province of Saudi Arabia. Trans R Soc Trop Med Hyg 1984;78:792–794.
26.
Srinivasan K: Ischemic cerebrovascular disease in the young. Two common causes in India. Stroke 1984;12:460–466.
27.
Ashok PP, Radhakrishan K, Sridharan R, El-Mangoush MA: Incidence and pattern of cerebrovascular disease in Benghazi, Libya. J Neurol Neurosurg Psychiatry 1986;49:512–523.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.